Skip to content

When Beijing and Brussels Collide: The Compliance Trap No One Is Talking About (yet)

May 2, 20262 minute read

Two Chinese State Council decrees. No transition period. No implementing guidelines. Immediate effect.

If your organization is subject to NIS2, the CRA, or GDPR — and you have Chinese suppliers or processors — you are now operating inside a structural legal conflict. 🌍

What Happened
Decree 834 (April 7, 2026) — China’s first dedicated supply chain security regulation — prohibits supply chain-related “investigations or information collection” within Chinese territory.

The scope is undefined. No implementing rules exist. ❗

Regulatory collision:
• NIS2 Article 21 → requires supplier security assessments
• CRA → requires conformity assessments on Chinese hardware/software
• GDPR Article 28 → requires audit rights over processors
All of that is now potentially in scope of Decree 834.

Decree 835 (April 13, 2026) — empowers China’s Ministry of Justice to designate foreign regulatory measures as “undue extraterritorial jurisdiction” — and prohibit compliance.
No designations yet. Criteria undefined. Discretion is broad.

The Trap
• Comply fully with NIS2/CRA/GDPR → risk triggering PRC investigation or countermeasures
• Pull back to avoid PRC exposure → breach binding EU obligations
Neither option is clean. This is a structural gap.

Exposure on both sides:
• PRC civil claims under Anti-Foreign Sanctions Law already active (RMB 99.7M settlement, 2024)
• EU fines under NIS2 / CRA / GDPR → 2–4% of global turnover

A defensible position requires:
• Jurisdictional conflict mapping before enforcement
• Parallel documentation under EU + Chinese law
• Transfer impact assessments covering full PRC legal stack
• Contractual architecture allocating regulatory conflict risk clearly

How S8fe.ai Supports
We map cross-border obligations, identify conflict points in data flows and third-party relationships, and generate documentation defensible under both legal systems simultaneously.

If you are a DPO or GC with China exposure, the question is not whether this affects you. It is whether you have a documented position before your regulator asks.

Share this article

Back To Top